Skip to content

Targeting Personalized Brain States Reflecting Strong and Weak Corticospinal Tract Output in Real-time

Targeting Personalized Brain States Reflecting Strong and Weak Corticospinal Tract Output in Real-time

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06365086
Enrollment
21
Registered
2024-04-15
Start date
2023-01-27
Completion date
2025-01-01
Last updated
2025-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurotypical Adults

Brief summary

Transcranial magnetic stimulation (TMS) interventions could feasibly strengthen residual corticospinal tract (CST) connections and enhance recovery of paretic hand function after stroke. To maximize the therapeutic effects of such interventions, they must be delivered during poststroke brain activity patterns during which TMS best activates the residual corticospinal tract and enhances neural transmission within it (i.e., brain state-dependent TMS). In this study, the investigators will test the feasibility of real-time, personalized brain state-dependent TMS in neurotypical adults. Participants will visit the laboratory for one day of testing. Upon arrival, participants will provide their informed consent; afterwards, they will complete eligibility screening. The investigators will then place recording electrodes on the scalp using a swim-type cap and on the left first dorsal interosseous, abductor pollicis brevis, and extensor digitorum communis muscles. After determining the location at which TMS best elicits muscle twitches in the left first dorsal interosseous, the investigators will determine the lowest possible intensity at which TMS elicits muscle twitches at least half of the time in this muscle. Then, the investigators will deliver 6 blocks of 100 single TMS pulses while the participant rests quietly with their eyes open; stimulation will be delivered at an intensity that is 20% greater than the lowest possible intensity at which TMS elicits muscle twitches at least half of the time. Afterwards, the investigators will use the muscle and brain activity recordings acquired during these 6 blocks to build a personalized mathematical model that identifies which patterns of brain activity correspond to the largest TMS-evoked muscle twitches. The investigators will then use this model to detect the occurrence of these brain activity patterns in real-time; when these patterns are detected, single TMS pulses will be delivered. Afterwards, all recording electrodes will be removed, participation will be complete, and participants will leave the laboratory. The investigators will recruit a total of 16 neurotypical adults for this study.

Interventions

Single-pulse TMS will be applied to the right hemisphere during brain activity patterns associated with strong and weak corticospinal tract activation. Single-pulse TMS will also be applied to the right hemisphere during random brain activity patterns.

Sponsors

Emory University
CollaboratorOTHER
University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Participants will receive single-pulse TMS during personalized brain activity patterns reflecting either strong or weak corticospinal tract activation

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Right-hand dominance * Willingness to participate * Ability to provide informed consent

Exclusion criteria

* History of major neurological, orthopedic, psychiatric, or cardiovascular disease * Presence of contraindications to transcranial magnetic stimulation (TMS) or peripheral nerve stimulation (PNS), including: * history of adverse reactions to TMS or PNS * history of stroke or head injury * metal in head, eyes, neck, chest/trunk, or arms, including but not limited to shrapnel, * surgical clips, fragments from metalworking, fragments from welding * implanted devices * history of frequent and severe headaches or migraines * immediate family history of seizure or epilepsy * personal history of seizure or epilepsy * current, suspected, or planned pregnancy * current or recent (within the last 3 months) use of medications acting on the central nervous system, including but not limited to: antipsychotic drugs, antidepressants, benzodiazepines, prescription stimulants

Design outcomes

Primary

MeasureTime frameDescription
Motor-evoked Potential (MEP) Amplitudessingle sessionPeak-to-peak MEP amplitudes elicited by single transcranial magnetic stimulation (TMS) pulses delivered during personalized strong and weak CST states will be measured from the left first dorsal interosseous muscle. At the individual participant level, all MEP amplitudes will be normalized to the mean MEP amplitude observed in that participant. Mean normalized MEP amplitudes will be compared across CST states.

Secondary

MeasureTime frameDescription
State-targeting Accuracysingle sessionAn offline version of the real-time EEG analysis algorithm will be used to determine the brain state (i.e., strong or weak CST states, or neither) immediately preceding delivery of each single TMS pulse. The proportion of trials during which the online and offline versions of the real-time EEG analysis algorithm produce the same brain state prediction will be calculated per participant and used as a state-targeting accuracy metric. State-targeting accuracy metrics will be compared to the theoretical chance level (0.5).

Countries

United States

Participant flow

Pre-assignment details

There were no specific pre-assignment procedures or events for this study.

Participants by arm

ArmCount
Healthy Adults
Healthy adults received single-pulse TMS the right motor cortex during personalized brain states reflecting strong corticospinal tract (CST) activation (strong CST states), weak CST states, and random CST states. Stimulation was delivered at 120% of resting motor threshold and motor-evoked potentials (MEPs) were recorded from the left first dorsal interosseous muscle.
19
Total19

Baseline characteristics

CharacteristicHealthy Adults
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
19 Participants
Age, Continuous20.8 years
STANDARD_DEVIATION 3.05
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
6 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
8 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
7 Participants
Race (NIH/OMB)
White
1 Participants
Region of Enrollment
United States
19 Participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
0 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

Primary

Motor-evoked Potential (MEP) Amplitudes

Peak-to-peak MEP amplitudes elicited by single transcranial magnetic stimulation (TMS) pulses delivered during personalized strong and weak CST states will be measured from the left first dorsal interosseous muscle. At the individual participant level, all MEP amplitudes will be normalized to the mean MEP amplitude observed in that participant. Mean normalized MEP amplitudes will be compared across CST states.

Time frame: single session

ArmMeasureValue (MEAN)Dispersion
Strong CST StatesMotor-evoked Potential (MEP) Amplitudes1.13 arbitrary units (normalized microvolts)Standard Error 0.05
Weak CST StatesMotor-evoked Potential (MEP) Amplitudes0.96 arbitrary units (normalized microvolts)Standard Error 0.04
Random CST StatesMotor-evoked Potential (MEP) Amplitudes0.90 arbitrary units (normalized microvolts)Standard Error 0.05
Secondary

State-targeting Accuracy

An offline version of the real-time EEG analysis algorithm will be used to determine the brain state (i.e., strong or weak CST states, or neither) immediately preceding delivery of each single TMS pulse. The proportion of trials during which the online and offline versions of the real-time EEG analysis algorithm produce the same brain state prediction will be calculated per participant and used as a state-targeting accuracy metric. State-targeting accuracy metrics will be compared to the theoretical chance level (0.5).

Time frame: single session

ArmMeasureValue (MEAN)Dispersion
Strong CST StatesState-targeting Accuracy94.5 percentage of trials accurately targetedStandard Error 1.1
Weak CST StatesState-targeting Accuracy89.5 percentage of trials accurately targetedStandard Error 2.7
Random CST StatesState-targeting AccuracyNA percentage of trials accurately targeted

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026